In addition, the number and activity of CD4+ and CD8+ T cells were increased in the tumors and DLNs of breast cancer-bearing immunocompetent mice by the combined administration of TEM and anti-PD-L1, thereby inducing anti-cancer immunity. This evidence concerns the gene CD4 and breast cancer.